Deleted in breast cancer 1 suppresses B cell activation through RelB and is regulated by IKKα phosphorylation

Sinyi Kong, Hongxin Dong, Jianxun Song, Muthusamy Thiruppathi, Bellur S. Prabhakar, Quan Qiu, Zhenghong Lin, Eduardo Chini, Bin Zhang, Deyu Fang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Alternative NF-κB signaling is crucial for B cell activation and Ig production, and it is mainly regulated by the inhibitor of κ B kinase (IKK) regulatory complex. Dysregulation of alternative NF-κB signaling in B cells could therefore lead to hyperactive B cells and Ig overproduction. In our previous, study we found that deleted in breast cancer 1 (DBC1) is a suppressor of the alternative NF-κB pathway to attenuate B cell activation. In this study, we report that loss of DBC1 results in spontaneous overproduction of Ig in mice after 10 mo of age. Using a double mutant genetic model, we confirm that DBC1 suppresses B cell activation through RelB inhibition. At the molecular level, we show that DBC1 interacts with alternative NF-κB members RelB and p52 through its leucine zipper domain. In addition, phosphorylation of DBC1 at its C terminus by IKKα facilitates its interaction with RelB and IKKα, indicating that DBC1-mediated suppression of alternative NF-κB is regulated by IKKα. Our results define the molecular mechanism of DBC1 inhibition of alternative NF-κB activation in suppressing B cell activation.

Original languageEnglish (US)
Pages (from-to)3685-3693
Number of pages9
JournalJournal of Immunology
Volume195
Issue number8
DOIs
StatePublished - Oct 15 2015

Fingerprint

B-Lymphocytes
Phosphorylation
Breast Neoplasms
Leucine Zippers
Genetic Models
Phosphotransferases

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Kong, S., Dong, H., Song, J., Thiruppathi, M., Prabhakar, B. S., Qiu, Q., ... Fang, D. (2015). Deleted in breast cancer 1 suppresses B cell activation through RelB and is regulated by IKKα phosphorylation. Journal of Immunology, 195(8), 3685-3693. https://doi.org/10.4049/jimmunol.1500713
Kong, Sinyi ; Dong, Hongxin ; Song, Jianxun ; Thiruppathi, Muthusamy ; Prabhakar, Bellur S. ; Qiu, Quan ; Lin, Zhenghong ; Chini, Eduardo ; Zhang, Bin ; Fang, Deyu. / Deleted in breast cancer 1 suppresses B cell activation through RelB and is regulated by IKKα phosphorylation. In: Journal of Immunology. 2015 ; Vol. 195, No. 8. pp. 3685-3693.
@article{2960c1f8e7ec4ec98b79bdb254e9bb9a,
title = "Deleted in breast cancer 1 suppresses B cell activation through RelB and is regulated by IKKα phosphorylation",
abstract = "Alternative NF-κB signaling is crucial for B cell activation and Ig production, and it is mainly regulated by the inhibitor of κ B kinase (IKK) regulatory complex. Dysregulation of alternative NF-κB signaling in B cells could therefore lead to hyperactive B cells and Ig overproduction. In our previous, study we found that deleted in breast cancer 1 (DBC1) is a suppressor of the alternative NF-κB pathway to attenuate B cell activation. In this study, we report that loss of DBC1 results in spontaneous overproduction of Ig in mice after 10 mo of age. Using a double mutant genetic model, we confirm that DBC1 suppresses B cell activation through RelB inhibition. At the molecular level, we show that DBC1 interacts with alternative NF-κB members RelB and p52 through its leucine zipper domain. In addition, phosphorylation of DBC1 at its C terminus by IKKα facilitates its interaction with RelB and IKKα, indicating that DBC1-mediated suppression of alternative NF-κB is regulated by IKKα. Our results define the molecular mechanism of DBC1 inhibition of alternative NF-κB activation in suppressing B cell activation.",
author = "Sinyi Kong and Hongxin Dong and Jianxun Song and Muthusamy Thiruppathi and Prabhakar, {Bellur S.} and Quan Qiu and Zhenghong Lin and Eduardo Chini and Bin Zhang and Deyu Fang",
year = "2015",
month = "10",
day = "15",
doi = "10.4049/jimmunol.1500713",
language = "English (US)",
volume = "195",
pages = "3685--3693",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

Kong, S, Dong, H, Song, J, Thiruppathi, M, Prabhakar, BS, Qiu, Q, Lin, Z, Chini, E, Zhang, B & Fang, D 2015, 'Deleted in breast cancer 1 suppresses B cell activation through RelB and is regulated by IKKα phosphorylation', Journal of Immunology, vol. 195, no. 8, pp. 3685-3693. https://doi.org/10.4049/jimmunol.1500713

Deleted in breast cancer 1 suppresses B cell activation through RelB and is regulated by IKKα phosphorylation. / Kong, Sinyi; Dong, Hongxin; Song, Jianxun; Thiruppathi, Muthusamy; Prabhakar, Bellur S.; Qiu, Quan; Lin, Zhenghong; Chini, Eduardo; Zhang, Bin; Fang, Deyu.

In: Journal of Immunology, Vol. 195, No. 8, 15.10.2015, p. 3685-3693.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Deleted in breast cancer 1 suppresses B cell activation through RelB and is regulated by IKKα phosphorylation

AU - Kong, Sinyi

AU - Dong, Hongxin

AU - Song, Jianxun

AU - Thiruppathi, Muthusamy

AU - Prabhakar, Bellur S.

AU - Qiu, Quan

AU - Lin, Zhenghong

AU - Chini, Eduardo

AU - Zhang, Bin

AU - Fang, Deyu

PY - 2015/10/15

Y1 - 2015/10/15

N2 - Alternative NF-κB signaling is crucial for B cell activation and Ig production, and it is mainly regulated by the inhibitor of κ B kinase (IKK) regulatory complex. Dysregulation of alternative NF-κB signaling in B cells could therefore lead to hyperactive B cells and Ig overproduction. In our previous, study we found that deleted in breast cancer 1 (DBC1) is a suppressor of the alternative NF-κB pathway to attenuate B cell activation. In this study, we report that loss of DBC1 results in spontaneous overproduction of Ig in mice after 10 mo of age. Using a double mutant genetic model, we confirm that DBC1 suppresses B cell activation through RelB inhibition. At the molecular level, we show that DBC1 interacts with alternative NF-κB members RelB and p52 through its leucine zipper domain. In addition, phosphorylation of DBC1 at its C terminus by IKKα facilitates its interaction with RelB and IKKα, indicating that DBC1-mediated suppression of alternative NF-κB is regulated by IKKα. Our results define the molecular mechanism of DBC1 inhibition of alternative NF-κB activation in suppressing B cell activation.

AB - Alternative NF-κB signaling is crucial for B cell activation and Ig production, and it is mainly regulated by the inhibitor of κ B kinase (IKK) regulatory complex. Dysregulation of alternative NF-κB signaling in B cells could therefore lead to hyperactive B cells and Ig overproduction. In our previous, study we found that deleted in breast cancer 1 (DBC1) is a suppressor of the alternative NF-κB pathway to attenuate B cell activation. In this study, we report that loss of DBC1 results in spontaneous overproduction of Ig in mice after 10 mo of age. Using a double mutant genetic model, we confirm that DBC1 suppresses B cell activation through RelB inhibition. At the molecular level, we show that DBC1 interacts with alternative NF-κB members RelB and p52 through its leucine zipper domain. In addition, phosphorylation of DBC1 at its C terminus by IKKα facilitates its interaction with RelB and IKKα, indicating that DBC1-mediated suppression of alternative NF-κB is regulated by IKKα. Our results define the molecular mechanism of DBC1 inhibition of alternative NF-κB activation in suppressing B cell activation.

UR - http://www.scopus.com/inward/record.url?scp=84943575351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943575351&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1500713

DO - 10.4049/jimmunol.1500713

M3 - Article

C2 - 26378077

AN - SCOPUS:84943575351

VL - 195

SP - 3685

EP - 3693

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -